Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review.

Hsiao, S-H; Chang, H-J; Hsieh, T-H; Kao, S-M; Yeh, P-Y; Wu, T-J

Hsiao, S-H; Chang, H-J; Hsieh, T-H; Kao, S-M; Yeh, P-Y; Wu, T-J.

Affiliation

Hsiao SH; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
Chang HJ; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
Hsieh TH; Department of Internal Medicine, Medical college and Hospital, National Cheng Kung University, Tainan, Taiwan.
Kao SM; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
Yeh PY; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
Wu TJ; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.

J Clin Pharm Ther ; 41(5): 575-8, 2016 Oct.

Article de En | MEDLINE | ID: mdl-27430348

Sujet(s)
Mots clés

atorvastatin; drug interaction; fluconazole; rhabdomyolysis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rhabdomyolyse / Fluconazole / Inhibiteurs du cytochrome P-450 CYP3A / Atorvastatine Limites: Aged / Female / Humans Langue: En Journal: J Clin Pharm Ther Sujet du journal: FARMACIA / TERAPEUTICA Année: 2016 Type de document: Article Pays d'affiliation: Taïwan

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google